Gwenn Hansen sold $109K of Nurix Therapeutics, Inc. (NRIX) stock

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 4,356 shares of NRIX stock worth $109K, per an SEC Form 4 filed Aug 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Aug 5, 2026.

NRIX has moved -11.0% since the trade date, from $25.12 to $22.35 (Oct 9, 2026 close).